首页> 外文期刊>Clinical rheumatology >Serum human cartilage glycoprotein-39 in patients with systemic sclerosis: relationship to skin and articular manifestation.
【24h】

Serum human cartilage glycoprotein-39 in patients with systemic sclerosis: relationship to skin and articular manifestation.

机译:系统性硬化患者的血清人软骨糖蛋白39:与皮肤和关节表现的关系。

获取原文
获取原文并翻译 | 示例
       

摘要

Human cartilage glycoprotein-39 (HC gp-30) is a secretory protein of several types of cells including chondrocytes. It has been suggested to be a laboratory index of joint damage. Thirty-two patients with systemic sclerosis (SSc) and 22 age-matched controls were investigated. An increased serum HC gp-39 level was shown in SSc patients and was found to correlate with inflammatory indices. There was no correlation with modified Rodnan score, joint involvement, or duration of symptoms of SSc. The obtained results indicate for possible relationship of HCgp-39 to inflammation but do not suggest determination of HC gp-39 as clinically applicable index of articular involvement in SSc patients.
机译:人软骨糖蛋白39(HC gp-30)是包括软骨细胞在内的几种细胞的分泌蛋白。已经有人提出将其作为关节损伤的实验室指标。调查了32例系统性硬化症(SSc)患者和22名年龄匹配的对照者。 SSc患者的血清HC gp-39水平升高,并与炎症指数相关。与改良的Rodnan评分,关节受累或SSc症状持续时间无关。获得的结果表明HCgp-39与炎症的可能关系,但没有建议确定HCgp-39作为SSc患者关节受累的临床适用指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号